Concepedia

Noah Gregory Shuart

NG

Statistics

Publications

9

Citations

585

H-Index

9

Active since

2001

Affiliations

Xenon Pharmaceuticals (Canada)(Current)

Howard Hughes Medical Institute

Simon Fraser University

University of Washington

Noah Gregory Shuart is an author at Xenon Pharmaceuticals (Canada) specializing in molecular pharmacology, pharmacology, and medicine.

Publications per year

2001–2024

9

Publications

9

Inhibitory effects of cannabidiol on voltage-dependent sodium currents

Mohammad‐Reza Ghovanloo, Noah Gregory Shuart, Janette Mezeyova et al. · Journal of Biological Chemistry · 2018 · 207 citations · Full text

Medicine, Neuroscience, Pharmacology +14

Molecular mechanism for 3:1 subunit stoichiometry of rod cyclic nucleotide-gated ion channels

Noah Gregory Shuart, Yoni Haitin, Stacey S. Camp et al. · Nature Communications · 2011 · 102 citations · Full text

Natural Sciences, Biophysics, Molecular Biology +15

Selective NaV1.7 Antagonists with Long Residence Time Show Improved Efficacy against Inflammatory and Neuropathic Pain

Girish Bankar, Samuel J. Goodchild, Sarah Howard et al. · Cell Reports · 2018 · 77 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Discovery of Aryl Sulfonamides as Isoform-Selective Inhibitors of Na<sub>V</sub>1.7 with Efficacy in Rodent Pain Models

Thilo Focken, Shifeng Liu, Navjot Chahal et al. · ACS Medicinal Chemistry Letters · 2016 · 72 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Identification of CNS-Penetrant Aryl Sulfonamides as Isoform-Selective Na<sub>V</sub>1.6 Inhibitors with Efficacy in Mouse Models of Epilepsy

Thilo Focken, Kristen Burford, Michael Grimwood et al. · Journal of Medicinal Chemistry · 2019 · 32 citations · Full text

Medicine, Neuroscience, Pharmacology +15

1–5 of 9